Clinical Trials
3 trialsNCT02176967 2026-05-05
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Children's Oncology Group
Phase 3 Active not recruiting
NCT00033293 2023-04-18
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Children's Oncology Group
Phase 3 Completed
NCT00416559 2013-09-20
Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only
National Cancer Institute (NCI)
Phase 2 Unknown